 | • レポートコード：MRC308GR11400 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のヘモフィルス・パラスイス二価ワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のヘモフィルス・パラスイス二価ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– ヘモフィルス・パラスイス二価ワクチンの成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
ヘモフィルス・パラスイス二価ワクチン市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・二価不活化ワクチン、三価不活化ワクチン、四価不活化ワクチン
用途別セグメント
・子豚、成豚
主要な市場プレーヤー
・Zoetis、Boehringer-Ingelheim、Eurovet、Hipra、Nisseiken、Merck Animal Health、SPAH、Pulike Biological Engineering、China Animal Husbandry Industry、Wuhan Keqian Biology、Wo Hua Biotech、Zhejiang Ceva Ebvac Biotech、Luoyang Huizhong Biotech、Beijing Centrebio Biology、Shandong Huahong Bioengineering、Ringpu
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、ヘモフィルス・パラスイス二価ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヘモフィルス・パラスイス二価ワクチンメーカーの企業概要、2019年～2022年までのヘモフィルス・パラスイス二価ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヘモフィルス・パラスイス二価ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ヘモフィルス・パラスイス二価ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのヘモフィルス・パラスイス二価ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのヘモフィルス・パラスイス二価ワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびヘモフィルス・パラスイス二価ワクチンの産業チェーンを掲載しています。
・第14、15章では、ヘモフィルス・パラスイス二価ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– ヘモフィルス・パラスイス二価ワクチンの概要
– 種類別分析（2018年vs2022年vs2029年）：二価不活化ワクチン、三価不活化ワクチン、四価不活化ワクチン
– 用途別分析（2018年vs2022年vs2029年）：子豚、成豚
– 世界のヘモフィルス・パラスイス二価ワクチン市場規模・予測
– 世界のヘモフィルス・パラスイス二価ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Zoetis、Boehringer-Ingelheim、Eurovet、Hipra、Nisseiken、Merck Animal Health、SPAH、Pulike Biological Engineering、China Animal Husbandry Industry、Wuhan Keqian Biology、Wo Hua Biotech、Zhejiang Ceva Ebvac Biotech、Luoyang Huizhong Biotech、Beijing Centrebio Biology、Shandong Huahong Bioengineering、Ringpu
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：二価不活化ワクチン、三価不活化ワクチン、四価不活化ワクチン
・用途別分析2018年-2029年：子豚、成豚
・ヘモフィルス・パラスイス二価ワクチンの北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ヘモフィルス・パラスイス二価ワクチンのヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヘモフィルス・パラスイス二価ワクチンのアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヘモフィルス・パラスイス二価ワクチンの南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ヘモフィルス・パラスイス二価ワクチンの中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Haemophilus Parasuis Bivalent Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Bivalent Inactivated Vaccine
1.3.3 Trivalent Inactivated Vaccine
1.3.4 Quadrivalent Inactivated Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Piglets
1.4.3 Adults Pigs
1.5 Global Haemophilus Parasuis Bivalent Vaccine Market Size & Forecast
1.5.1 Global Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity (2018-2029)
1.5.3 Global Haemophilus Parasuis Bivalent Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business
2.1.3 Zoetis Haemophilus Parasuis Bivalent Vaccine Product and Services
2.1.4 Zoetis Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Zoetis Recent Developments/Updates
2.2 Boehringer-Ingelheim
2.2.1 Boehringer-Ingelheim Details
2.2.2 Boehringer-Ingelheim Major Business
2.2.3 Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Product and Services
2.2.4 Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer-Ingelheim Recent Developments/Updates
2.3 Eurovet
2.3.1 Eurovet Details
2.3.2 Eurovet Major Business
2.3.3 Eurovet Haemophilus Parasuis Bivalent Vaccine Product and Services
2.3.4 Eurovet Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Eurovet Recent Developments/Updates
2.4 Hipra
2.4.1 Hipra Details
2.4.2 Hipra Major Business
2.4.3 Hipra Haemophilus Parasuis Bivalent Vaccine Product and Services
2.4.4 Hipra Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Hipra Recent Developments/Updates
2.5 Nisseiken
2.5.1 Nisseiken Details
2.5.2 Nisseiken Major Business
2.5.3 Nisseiken Haemophilus Parasuis Bivalent Vaccine Product and Services
2.5.4 Nisseiken Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Nisseiken Recent Developments/Updates
2.6 Merck Animal Health
2.6.1 Merck Animal Health Details
2.6.2 Merck Animal Health Major Business
2.6.3 Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Product and Services
2.6.4 Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck Animal Health Recent Developments/Updates
2.7 SPAH
2.7.1 SPAH Details
2.7.2 SPAH Major Business
2.7.3 SPAH Haemophilus Parasuis Bivalent Vaccine Product and Services
2.7.4 SPAH Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 SPAH Recent Developments/Updates
2.8 Pulike Biological Engineering
2.8.1 Pulike Biological Engineering Details
2.8.2 Pulike Biological Engineering Major Business
2.8.3 Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Product and Services
2.8.4 Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pulike Biological Engineering Recent Developments/Updates
2.9 China Animal Husbandry Industry
2.9.1 China Animal Husbandry Industry Details
2.9.2 China Animal Husbandry Industry Major Business
2.9.3 China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Product and Services
2.9.4 China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 China Animal Husbandry Industry Recent Developments/Updates
2.10 Wuhan Keqian Biology
2.10.1 Wuhan Keqian Biology Details
2.10.2 Wuhan Keqian Biology Major Business
2.10.3 Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
2.10.4 Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wuhan Keqian Biology Recent Developments/Updates
2.11 Wo Hua Biotech
2.11.1 Wo Hua Biotech Details
2.11.2 Wo Hua Biotech Major Business
2.11.3 Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
2.11.4 Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Wo Hua Biotech Recent Developments/Updates
2.12 Zhejiang Ceva Ebvac Biotech
2.12.1 Zhejiang Ceva Ebvac Biotech Details
2.12.2 Zhejiang Ceva Ebvac Biotech Major Business
2.12.3 Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
2.12.4 Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Zhejiang Ceva Ebvac Biotech Recent Developments/Updates
2.13 Luoyang Huizhong Biotech
2.13.1 Luoyang Huizhong Biotech Details
2.13.2 Luoyang Huizhong Biotech Major Business
2.13.3 Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
2.13.4 Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Luoyang Huizhong Biotech Recent Developments/Updates
2.14 Beijing Centrebio Biology
2.14.1 Beijing Centrebio Biology Details
2.14.2 Beijing Centrebio Biology Major Business
2.14.3 Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
2.14.4 Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Beijing Centrebio Biology Recent Developments/Updates
2.15 Shandong Huahong Bioengineering
2.15.1 Shandong Huahong Bioengineering Details
2.15.2 Shandong Huahong Bioengineering Major Business
2.15.3 Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Product and Services
2.15.4 Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Shandong Huahong Bioengineering Recent Developments/Updates
2.16 Ringpu
2.16.1 Ringpu Details
2.16.2 Ringpu Major Business
2.16.3 Ringpu Haemophilus Parasuis Bivalent Vaccine Product and Services
2.16.4 Ringpu Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Ringpu Recent Developments/Updates
3 Competitive Environment: Haemophilus Parasuis Bivalent Vaccine by Manufacturer
3.1 Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Haemophilus Parasuis Bivalent Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Haemophilus Parasuis Bivalent Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Haemophilus Parasuis Bivalent Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Haemophilus Parasuis Bivalent Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Haemophilus Parasuis Bivalent Vaccine Manufacturer Market Share in 2022
3.5 Haemophilus Parasuis Bivalent Vaccine Market: Overall Company Footprint Analysis
3.5.1 Haemophilus Parasuis Bivalent Vaccine Market: Region Footprint
3.5.2 Haemophilus Parasuis Bivalent Vaccine Market: Company Product Type Footprint
3.5.3 Haemophilus Parasuis Bivalent Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Haemophilus Parasuis Bivalent Vaccine Market Size by Region
4.1.1 Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Haemophilus Parasuis Bivalent Vaccine Average Price by Region (2018-2029)
4.2 North America Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029)
4.3 Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029)
4.5 South America Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type (2018-2029)
5.3 Global Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application (2018-2029)
6.3 Global Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Haemophilus Parasuis Bivalent Vaccine Market Size by Country
7.3.1 North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Haemophilus Parasuis Bivalent Vaccine Market Size by Country
8.3.1 Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Market Size by Region
9.3.1 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Haemophilus Parasuis Bivalent Vaccine Market Size by Country
10.3.1 South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Market Size by Country
11.3.1 Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Haemophilus Parasuis Bivalent Vaccine Market Drivers
12.2 Haemophilus Parasuis Bivalent Vaccine Market Restraints
12.3 Haemophilus Parasuis Bivalent Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Haemophilus Parasuis Bivalent Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Haemophilus Parasuis Bivalent Vaccine
13.3 Haemophilus Parasuis Bivalent Vaccine Production Process
13.4 Haemophilus Parasuis Bivalent Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Haemophilus Parasuis Bivalent Vaccine Typical Distributors
14.3 Haemophilus Parasuis Bivalent Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Zoetis Basic Information, Manufacturing Base and Competitors
Table 4. Zoetis Major Business
Table 5. Zoetis Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 6. Zoetis Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Zoetis Recent Developments/Updates
Table 8. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer-Ingelheim Major Business
Table 10. Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 11. Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boehringer-Ingelheim Recent Developments/Updates
Table 13. Eurovet Basic Information, Manufacturing Base and Competitors
Table 14. Eurovet Major Business
Table 15. Eurovet Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 16. Eurovet Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Eurovet Recent Developments/Updates
Table 18. Hipra Basic Information, Manufacturing Base and Competitors
Table 19. Hipra Major Business
Table 20. Hipra Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 21. Hipra Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Hipra Recent Developments/Updates
Table 23. Nisseiken Basic Information, Manufacturing Base and Competitors
Table 24. Nisseiken Major Business
Table 25. Nisseiken Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 26. Nisseiken Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Nisseiken Recent Developments/Updates
Table 28. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 29. Merck Animal Health Major Business
Table 30. Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 31. Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Merck Animal Health Recent Developments/Updates
Table 33. SPAH Basic Information, Manufacturing Base and Competitors
Table 34. SPAH Major Business
Table 35. SPAH Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 36. SPAH Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. SPAH Recent Developments/Updates
Table 38. Pulike Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 39. Pulike Biological Engineering Major Business
Table 40. Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 41. Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Pulike Biological Engineering Recent Developments/Updates
Table 43. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 44. China Animal Husbandry Industry Major Business
Table 45. China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 46. China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. China Animal Husbandry Industry Recent Developments/Updates
Table 48. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 49. Wuhan Keqian Biology Major Business
Table 50. Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 51. Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Wuhan Keqian Biology Recent Developments/Updates
Table 53. Wo Hua Biotech Basic Information, Manufacturing Base and Competitors
Table 54. Wo Hua Biotech Major Business
Table 55. Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 56. Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Wo Hua Biotech Recent Developments/Updates
Table 58. Zhejiang Ceva Ebvac Biotech Basic Information, Manufacturing Base and Competitors
Table 59. Zhejiang Ceva Ebvac Biotech Major Business
Table 60. Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 61. Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Zhejiang Ceva Ebvac Biotech Recent Developments/Updates
Table 63. Luoyang Huizhong Biotech Basic Information, Manufacturing Base and Competitors
Table 64. Luoyang Huizhong Biotech Major Business
Table 65. Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 66. Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Luoyang Huizhong Biotech Recent Developments/Updates
Table 68. Beijing Centrebio Biology Basic Information, Manufacturing Base and Competitors
Table 69. Beijing Centrebio Biology Major Business
Table 70. Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 71. Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Beijing Centrebio Biology Recent Developments/Updates
Table 73. Shandong Huahong Bioengineering Basic Information, Manufacturing Base and Competitors
Table 74. Shandong Huahong Bioengineering Major Business
Table 75. Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 76. Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Shandong Huahong Bioengineering Recent Developments/Updates
Table 78. Ringpu Basic Information, Manufacturing Base and Competitors
Table 79. Ringpu Major Business
Table 80. Ringpu Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 81. Ringpu Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Ringpu Recent Developments/Updates
Table 83. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Doses)
Table 84. Global Haemophilus Parasuis Bivalent Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 86. Market Position of Manufacturers in Haemophilus Parasuis Bivalent Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Haemophilus Parasuis Bivalent Vaccine Production Site of Key Manufacturer
Table 88. Haemophilus Parasuis Bivalent Vaccine Market: Company Product Type Footprint
Table 89. Haemophilus Parasuis Bivalent Vaccine Market: Company Product Application Footprint
Table 90. Haemophilus Parasuis Bivalent Vaccine New Market Entrants and Barriers to Market Entry
Table 91. Haemophilus Parasuis Bivalent Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 93. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 94. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 97. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 98. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 99. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 100. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 103. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 104. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 105. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 106. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 109. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 110. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 111. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 112. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 113. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 114. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 115. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 116. North America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 119. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 120. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 121. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 122. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 123. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 124. Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 127. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 128. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 129. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 130. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 131. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 132. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 135. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 136. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 137. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 138. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 139. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 140. South America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 143. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 144. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 145. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 146. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 147. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 148. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Haemophilus Parasuis Bivalent Vaccine Raw Material
Table 151. Key Manufacturers of Haemophilus Parasuis Bivalent Vaccine Raw Materials
Table 152. Haemophilus Parasuis Bivalent Vaccine Typical Distributors
Table 153. Haemophilus Parasuis Bivalent Vaccine Typical Customers
List of Figures
Figure 1. Haemophilus Parasuis Bivalent Vaccine Picture
Figure 2. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Bivalent Inactivated Vaccine Examples
Figure 5. Trivalent Inactivated Vaccine Examples
Figure 6. Quadrivalent Inactivated Vaccine Examples
Figure 7. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Application in 2022
Figure 9. Piglets Examples
Figure 10. Adults Pigs Examples
Figure 11. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity (2018-2029) & (K Doses)
Figure 14. Global Haemophilus Parasuis Bivalent Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 15. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Haemophilus Parasuis Bivalent Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Haemophilus Parasuis Bivalent Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Haemophilus Parasuis Bivalent Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 30. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 33. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Haemophilus Parasuis Bivalent Vaccine Market Drivers
Figure 74. Haemophilus Parasuis Bivalent Vaccine Market Restraints
Figure 75. Haemophilus Parasuis Bivalent Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Haemophilus Parasuis Bivalent Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Haemophilus Parasuis Bivalent Vaccine
Figure 79. Haemophilus Parasuis Bivalent Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source